CHE
Chemed Corporation
Set alert
534.72 USD -7.20 -1.33%
533.25 Day range 550.93
368.59 52-week range 552.72
- YTD
- +24.98%
- 1 year
- +17.67%
- Open
- 545.01
- Prev close
- 541.92
- Mkt cap
- 6.93B
- Vol
- 180.47K
- Avg vol
- 154.34K
- EPS
- 20.88
- P/E
- 25.61
- Div yield
- 0.52%
More statistics
- Low
- 533.25
- High
- 550.93
- Forward P/E
- 19.45
- Beta
- 0.51
- Short ratio
- 4.25
- Inst. own
- 105.43%
- Dividend
- 2.80
- Ex-div date
- Aug 16, 2026
- Earnings
- Feb 24, 2027
- 50-d avg
- 514.74
- 200-d avg
- 462.35
- 1y target
- 617.00
Financial health
Altman Z-Score
9.75 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 2
- P/B 1
Valuation
P/E 23.2×
FY 2016 5y median 30.5× FY 2025
P/S 2.4×
FY 2016 5y median 3.6× FY 2025
P/B 6.3×
FY 2016 5y median 7.9× FY 2025
P/FCF 18.9×
FY 2016 5y median 30.2× FY 2025
EV/EBITDA 14.8×
FY 2016 5y median 19.8× FY 2025
EV/Sales 2.5×
FY 2016 5y median 3.7× FY 2025
FCF Yield 5.3%
FY 2016 5y median 3.3% FY 2025
Profitability
Gross Margin 30.0%
FY 2016 5y median 35.3% FY 2025
Operating Margin 13.4%
FY 2016 5y median 15.1% FY 2025
Net Margin 10.5%
FY 2016 5y median 12.0% FY 2025
ROE 27.1%
FY 2016 5y median 27.1% FY 2025
ROIC 18.0%
FY 2016 5y median 19.4% FY 2025
ROA 16.2%
FY 2016 5y median 17.3% FY 2025
Growth (YoY)
Revenue 4.1%
FY 2016 FY 2025
Operating Income -7.7%
FY 2016 FY 2025
EPS (diluted) -7.4%
FY 2016 FY 2025
Free Cash Flow -11.5%
FY 2016 FY 2025
Financial Health
Current Ratio 1.1×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 1.0×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.2×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 193×
FY 2016 5y median 184× FY 2025
Dividends
Dividend Yield 0.5%
FY 2016 5y median 0.3% FY 2025
Payout Ratio 11.9%
FY 2016 5y median 8.8% FY 2025
Annual · latest fiscal year ends 2025-12-31